Abstract P2-05-14: New treatment options for metastatic breast cancer revealed by reverse-phase protein microarray and genomic profiling
Casey Williams(Creighton University), Brian Leyland‐Jones(Avera Health), Amy Krie(Amgen (United States)), Misty Small(Avera Health), Kirstin Williams(Avera Health), Brandon Young(Avera Health), Yuliang Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Michelle King(Cancer Institute (WIA)), Jennifer Carlson(Avera Health), Pradip De(University of South Dakota), Jessica Klein(Cancer Institute (WIA)), Brigitte Cyr(Avera Health), Scooter Willis(Avera Health), Nandini Dey(University of South Dakota)
Cited by 0
Related Papers
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
|Nature Medicine|2019|726
RET rearrangements are actionable alterations in breast cancer
|Nature Communications|2018|127